Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ACTINOGEN-MEDICAL-LIMITED-10355426/news/Actinogen-Medical-Limited-Announces-First-Patient-Treated-in-XanaMIA-Phase-2b-Alzheimer-s-Disease-Tr-46437754/?utm_source=whatsapp&utm_medium=social&utm_campaign=share